Positive airway pressure therapy in patients with opioid-related central sleep apnea

Troitino, Anthony; Labedi, Nawman; Kufel, Thomas J.; El-Solh, Ali

doi:10.1007/s11325-013-0894-4

Cited by 21 publications

(16 citation statements)

References 23 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…65 A recent retrospective review of patients with idiopathic and opioid-induced central sleep apnea found that ASV resulted in an AHI < 10/hour in 60% of opiate-induced CSA and 90% of idiopathic CSA. 66 However, two-thirds of the patients in this study were effectively managed with standard CPAP or BPAP. 66 Another retrospective study compared central sleep apnea in patients with CHF versus non-CHF patients.…”

Section: Asv For Idiopathic and Opioid-induced Central Sleep Apneamentioning

confidence: 75%

Auto-adjusting and Advanced Positive Airway Pressure Therapeutic Modalities

Ryden¹,

Bando²,

Aysola³

2014

Semin Respir Crit Care Med

View full text Add to dashboard Cite

Continuous positive airway pressure (CPAP) therapy is the first-line treatment for obstructive sleep apnea (OSA). Although the gold standard for the treatment of OSA, CPAP may not be the optimal modality to treat more complex sleep disordered breathing such as Cheyne-Stokes respirations, opioid-induced central apnea, and complex sleep disordered breathing related to chronic hypoventilation syndromes (obesity-hypoventilation syndrome, restrictive thoracic disease due to neuromuscular or thoracic cage disease, chronic obstructive pulmonary disease). Newer generation auto-adjusting PAP devices are increasingly being used to treat OSA. Advanced positive airway pressure modalities have been developed in an effort to improve treatment of the more complex sleep disordered breathing syndromes including automated servo ventilation and volume-targeted pressure-limited ventilation. This article is intended to provide the clinician reader with a description of newer PAP modalities, a review of evidence-supported indications for use, as well as to provide a framework for managing patients with advanced positive airway pressure therapy.

show abstract

Section: Asv For Idiopathic and Opioid-induced Central Sleep Apneamentioning

confidence: 75%

Auto-adjusting and Advanced Positive Airway Pressure Therapeutic Modalities

Ryden¹,

Bando²,

Aysola³

2014

Semin Respir Crit Care Med

View full text Add to dashboard Cite

show abstract

“…It is also used in the treatment of other forms of CSA, such as idiopathic CSA, CPAP-emerged CSA and opioid-induced CSA [53,54] . ASV devices automatically provide altering pressure support for each inspiration, ranging from a pre-set minimum level to a pre-set maximum level, to maintain moving target ventilation (determined based on volume or flow) determined by the patient's current breathing in addition to the back-up ventilation with variable respiratory rates (i.e., servo-control of ventilation) ( Figure 6).…”

Section: Asvmentioning

confidence: 99%

Positive airway pressure therapy for heart failure

Kato

Suda

Kasai

2014

WJC

View full text Add to dashboard Cite

“…Compliance with positive pressure therapy was quite low in one study of such patients. 9 Will treatment also lead to improvement in psychomotor vigilance? What if any affect will it have on daytime hypoventilation?…”

Section: Effect Of Opioids On Sleep and Breathing In Chronic Pain Patmentioning

confidence: 99%